Home
About
Overview Team History Awards
Tech
Technical Background Core Tech Pipeline Patents
News
News Articles
Recruitment
Patient Recruitment Trial Facilities R&D Pipeline
Partnerships
Contact
Join
Add Kunshi Jobs Campus
CN/EN
information
INFORMATION
Current Location: information>news>Structural basis for the inhibition of coronaviral main proteases by ensitrelvir
Structural basis for the inhibition of coronaviral main proteases by ensitrelvir
StructurePublication time：2023-07-07
About Rock Roc
RocRock Biotechnology, originally incubated in Berlin, Germany, was formally established in Shenzhen in May 2021. Currently, the company has successfully accomplished a tricentric configuration, positioning its domestic headquarters in Shenzhen, its production base in Suzhou, and maintaining its international hub in Berlin, Germany. Led by the returned Chinese scholars from Europe, RocRock Biotechnology has joined hands with doctorates from prestigious scientific research institutes and pharma
For more company information, please visit：https://www.rocrockbio.com
Media contact
Mr Chen

chenhongyi@rocrockbio.com

18869005090

Investment contact
Miss Lv

Cathy.Lv@rocrockbio.com

18551154509

Previous articleLong-Read Sequencing Reveals Extensive DNA Methylations in Human Gut Phagenome Contributed by Prevalently Phage-Encoded Methyltransferases
Next articleCKIP-1 couples Smurf1 ubiquitin ligase with Rpt6 subunit of proteasome to promote substrate degradation
Share：
About
Overview
Team
History
Awards
Tech
Technical Background
Core Tech
Pipeline
Patents
News
News
Articles
Patient Recruitment
Patient Recruitment
Trial Facilities
R&D Pipeline
Patient Recruitment
Contact
Jobs
Add Kunshi
Jobs
Campus
Rock Roc official account
Copyright © 2023 Rock Roc Biotechnology Co., Ltd。All Rights Reserved。苏ICP备2023037904号

0512-67998889(Suzhou)

18051093220(Shenzhen)

Cathy.Lv@rocrockbio.com(Suzhou)

lliangjing@rocrockbio.com (Shenzhen)